Exact Mass: 453.21709039999996
Exact Mass Matches: 453.21709039999996
Found 500 metabolites which its exact mass value is equals to given mass value 453.21709039999996,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
20-Oxo-leukotriene E4
C23H35NO6S (453.21849700000007)
20-oxo-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078). Leukotrienes are eicosanoids. The eicosanoids consist of the prostaglandins (PGs), thromboxanes (TXs), leukotrienes (LTs), and lipoxins (LXs). The PGs and TXs are collectively identified as prostanoids. Prostaglandins were originally shown to be synthesized in the prostate gland, thromboxanes from platelets (thrombocytes), and leukotrienes from leukocytes, hence the derivation of their names. All mammalian cells except erythrocytes synthesize eicosanoids. These molecules are extremely potent, able to cause profound physiological effects at very dilute concentrations. All eicosanoids function locally at the site of synthesis, through receptor-mediated G-protein linked signalling pathways. 20-oxo-leukotriene E4 is a metabolite through lipid oxidation of Leukotriene E4 (LTE4).Leukotriene E4 (LTE4) is a cysteinyl leukotriene. Cysteinyl leukotrienes (CysLTs) are a family of potent inflammatory mediators that appear to contribute to the pathophysiologic features of allergic rhinitis. Nasal blockage induced by CysLTs is mainly due to dilatation of nasal blood vessels, which can be induced by the nitric oxide produced through CysLT1 receptor activation. LTE4, activate contractile and inflammatory processes via specific interaction with putative seven transmembrane-spanning receptors that couple to G proteins and subsequent intracellular signaling pathways. LTE4 is metabolized from leukotriene C4 in a reaction catalyzed by gamma-glutamyl transpeptidase and a particulate dipeptidase from kidney. (PMID: 12607939, 12432945, 6311078)
2-(3-(2-Aminoethyl)-1h-indol-5-yloxy)acetyl-l-tyrosyl-glycinamide
C23H27N5O5 (453.20120920000005)
Benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone
2-[[N-Methyl-N-[5-guanidino-2-[(2-amino-3-methylbutyryl)amino]pentanoyl]hydrazino]phosphonyl]-2-hydroxyacetic acid methyl ester
N-(coumaroyl-O-hexoside)-spermidine
C22H35N3O7 (453.24748800000003)
Ala Ala His Arg
Ala Ala Arg His
Ala His Ala Arg
Ala His Ile Asn
Ala His Leu Asn
Ala His Asn Ile
Ala His Asn Leu
Ala His Gln Val
Ala His Arg Ala
Ala His Val Gln
Ala Ile His Asn
Ala Ile Asn His
Ala Leu His Asn
Ala Leu Asn His
Ala Asn His Ile
Ala Asn His Leu
Ala Asn Ile His
Ala Asn Leu His
Ala Asn Ser Tyr
C19H27N5O8 (453.18595419999997)
Ala Asn Tyr Ser
C19H27N5O8 (453.18595419999997)
Ala Gln His Val
Ala Gln Val His
Ala Arg Ala His
Ala Arg His Ala
Ala Ser Asn Tyr
C19H27N5O8 (453.18595419999997)
Ala Ser Tyr Asn
C19H27N5O8 (453.18595419999997)
Ala Val His Gln
Ala Val Gln His
Ala Tyr Asn Ser
C19H27N5O8 (453.18595419999997)
Ala Tyr Ser Asn
C19H27N5O8 (453.18595419999997)
Cys Phe Gly Lys
C20H31N5O5S (453.20457960000005)
Cys Phe Lys Gly
C20H31N5O5S (453.20457960000005)
Cys Gly Phe Lys
C20H31N5O5S (453.20457960000005)
Cys Gly Lys Phe
C20H31N5O5S (453.20457960000005)
Cys Lys Phe Gly
C20H31N5O5S (453.20457960000005)
Cys Lys Gly Phe
C20H31N5O5S (453.20457960000005)
Phe Cys Gly Lys
C20H31N5O5S (453.20457960000005)
Phe Cys Lys Gly
C20H31N5O5S (453.20457960000005)
Phe Gly Cys Lys
C20H31N5O5S (453.20457960000005)
Phe Gly Lys Cys
C20H31N5O5S (453.20457960000005)
Phe Lys Cys Gly
C20H31N5O5S (453.20457960000005)
Phe Lys Gly Cys
C20H31N5O5S (453.20457960000005)
Phe Asn Ser Ser
C19H27N5O8 (453.18595419999997)
Phe Ser Asn Ser
C19H27N5O8 (453.18595419999997)
Phe Ser Ser Asn
C19H27N5O8 (453.18595419999997)
Gly Cys Phe Lys
C20H31N5O5S (453.20457960000005)
Gly Cys Lys Phe
C20H31N5O5S (453.20457960000005)
Gly Phe Cys Lys
C20H31N5O5S (453.20457960000005)
Gly Phe Lys Cys
C20H31N5O5S (453.20457960000005)
Gly His Ile Gln
Gly His Leu Gln
Gly His Gln Ile
Gly His Gln Leu
Gly Ile His Gln
Gly Ile Gln His
Gly Lys Cys Phe
C20H31N5O5S (453.20457960000005)
Gly Lys Phe Cys
C20H31N5O5S (453.20457960000005)
Gly Lys Ser Tyr
Gly Lys Tyr Ser
Gly Leu His Gln
Gly Leu Gln His
Gly Asn Thr Tyr
C19H27N5O8 (453.18595419999997)
Gly Asn Tyr Thr
C19H27N5O8 (453.18595419999997)
Gly Gln His Ile
Gly Gln His Leu
Gly Gln Ile His
Gly Gln Leu His
Gly Gln Ser Tyr
C19H27N5O8 (453.18595419999997)
Gly Gln Tyr Ser
C19H27N5O8 (453.18595419999997)
Gly Ser Lys Tyr
Gly Ser Gln Tyr
C19H27N5O8 (453.18595419999997)
Gly Ser Tyr Lys
Gly Ser Tyr Gln
C19H27N5O8 (453.18595419999997)
Gly Thr Asn Tyr
C19H27N5O8 (453.18595419999997)
Gly Thr Tyr Asn
C19H27N5O8 (453.18595419999997)
Gly Tyr Lys Ser
Gly Tyr Asn Thr
C19H27N5O8 (453.18595419999997)
Gly Tyr Gln Ser
C19H27N5O8 (453.18595419999997)
Gly Tyr Ser Lys
Gly Tyr Ser Gln
C19H27N5O8 (453.18595419999997)
Gly Tyr Thr Asn
C19H27N5O8 (453.18595419999997)
His Ala Ala Arg
His Ala Ile Asn
His Ala Leu Asn
His Ala Asn Ile
His Ala Asn Leu
His Ala Gln Val
His Ala Arg Ala
His Ala Val Gln
His Gly Ile Gln
His Gly Leu Gln
His Gly Gln Ile
His Gly Gln Leu
His Ile Ala Asn
His Ile Gly Gln
His Ile Asn Ala
His Ile Gln Gly
His Leu Ala Asn
His Leu Gly Gln
His Leu Asn Ala
His Leu Gln Gly
His Asn Ala Ile
His Asn Ala Leu
His Asn Ile Ala
His Asn Leu Ala
His Asn Pro Ser
His Asn Ser Pro
His Pro Asn Ser
His Pro Ser Asn
His Gln Ala Val
His Gln Gly Ile
His Gln Gly Leu
His Gln Ile Gly
His Gln Leu Gly
His Gln Val Ala
His Arg Ala Ala
His Ser Asn Pro
His Ser Pro Asn
His Val Ala Gln
His Val Gln Ala
Ile Ala His Asn
Ile Ala Asn His
Ile Gly His Gln
Ile Gly Gln His
Ile His Ala Asn
Ile His Gly Gln
Ile His Asn Ala
Ile His Gln Gly
Ile Asn Ala His
Ile Asn His Ala
Ile Gln Gly His
Ile Gln His Gly
Lys Cys Phe Gly
C20H31N5O5S (453.20457960000005)
Lys Cys Gly Phe
C20H31N5O5S (453.20457960000005)
Lys Phe Cys Gly
C20H31N5O5S (453.20457960000005)
Lys Phe Gly Cys
C20H31N5O5S (453.20457960000005)
Lys Gly Cys Phe
C20H31N5O5S (453.20457960000005)
Lys Gly Phe Cys
C20H31N5O5S (453.20457960000005)
Lys Gly Ser Tyr
Lys Gly Tyr Ser
Lys Ser Gly Tyr
Lys Ser Tyr Gly
Lys Tyr Gly Ser
Lys Tyr Ser Gly
Leu Ala His Asn
Leu Ala Asn His
Leu Gly His Gln
Leu Gly Gln His
Leu His Ala Asn
Leu His Gly Gln
Leu His Asn Ala
Leu His Gln Gly
Leu Asn Ala His
Leu Asn His Ala
Leu Gln Gly His
Leu Gln His Gly
Asn Ala His Ile
Asn Ala His Leu
Asn Ala Ile His
Asn Ala Leu His
Asn Ala Ser Tyr
C19H27N5O8 (453.18595419999997)
Asn Ala Tyr Ser
C19H27N5O8 (453.18595419999997)
Asn Phe Ser Ser
C19H27N5O8 (453.18595419999997)
Asn Gly Thr Tyr
C19H27N5O8 (453.18595419999997)
Asn Gly Tyr Thr
C19H27N5O8 (453.18595419999997)
Asn His Ala Ile
Asn His Ala Leu
Asn His Ile Ala
Asn His Leu Ala
Asn His Pro Ser
Asn His Ser Pro
Asn Ile Ala His
Asn Ile His Ala
Asn Leu Ala His
Asn Leu His Ala
Asn Pro His Ser
Asn Pro Ser His
Asn Ser Ala Tyr
C19H27N5O8 (453.18595419999997)
Asn Ser Phe Ser
C19H27N5O8 (453.18595419999997)
Asn Ser His Pro
Asn Ser Pro His
Asn Ser Ser Phe
C19H27N5O8 (453.18595419999997)
Asn Ser Tyr Ala
C19H27N5O8 (453.18595419999997)
Asn Thr Gly Tyr
C19H27N5O8 (453.18595419999997)
Asn Thr Tyr Gly
C19H27N5O8 (453.18595419999997)
Asn Tyr Ala Ser
C19H27N5O8 (453.18595419999997)
Asn Tyr Gly Thr
C19H27N5O8 (453.18595419999997)
Asn Tyr Ser Ala
C19H27N5O8 (453.18595419999997)
Asn Tyr Thr Gly
C19H27N5O8 (453.18595419999997)
Pro His Asn Ser
Pro His Ser Asn
Pro Asn His Ser
Pro Asn Ser His
Pro Ser His Asn
Pro Ser Asn His
Gln Ala His Val
Gln Ala Val His
Gln Gly His Ile
Gln Gly His Leu
Gln Gly Ile His
Gln Gly Leu His
Gln Gly Ser Tyr
C19H27N5O8 (453.18595419999997)
Gln Gly Tyr Ser
C19H27N5O8 (453.18595419999997)
Gln His Ala Val
Gln His Gly Ile
Gln His Gly Leu
Gln His Ile Gly
Gln His Leu Gly
Gln His Val Ala
Gln Ile Gly His
Gln Ile His Gly
Gln Leu Gly His
Gln Leu His Gly
Gln Ser Gly Tyr
C19H27N5O8 (453.18595419999997)
Gln Ser Tyr Gly
C19H27N5O8 (453.18595419999997)
Gln Val Ala His
Gln Val His Ala
Gln Tyr Gly Ser
C19H27N5O8 (453.18595419999997)
Gln Tyr Ser Gly
C19H27N5O8 (453.18595419999997)
Arg Ala Ala His
Arg Ala His Ala
Arg His Ala Ala
Ser Ala Asn Tyr
C19H27N5O8 (453.18595419999997)
Ser Ala Tyr Asn
C19H27N5O8 (453.18595419999997)
Ser Phe Asn Ser
C19H27N5O8 (453.18595419999997)
Ser Phe Ser Asn
C19H27N5O8 (453.18595419999997)
Ser Gly Lys Tyr
Ser Gly Gln Tyr
C19H27N5O8 (453.18595419999997)
Ser Gly Tyr Lys
Ser Gly Tyr Gln
C19H27N5O8 (453.18595419999997)
Ser His Asn Pro
Ser His Pro Asn
Ser Lys Gly Tyr
Ser Lys Tyr Gly
Ser Asn Ala Tyr
C19H27N5O8 (453.18595419999997)
Ser Asn Phe Ser
C19H27N5O8 (453.18595419999997)
Ser Asn His Pro
Ser Asn Pro His
Ser Asn Ser Phe
C19H27N5O8 (453.18595419999997)
Ser Asn Tyr Ala
C19H27N5O8 (453.18595419999997)
Ser Pro His Asn
Ser Pro Asn His
Ser Gln Gly Tyr
C19H27N5O8 (453.18595419999997)
Ser Gln Tyr Gly
C19H27N5O8 (453.18595419999997)
Ser Ser Phe Asn
C19H27N5O8 (453.18595419999997)
Ser Ser Asn Phe
C19H27N5O8 (453.18595419999997)
Ser Tyr Ala Asn
C19H27N5O8 (453.18595419999997)
Ser Tyr Gly Lys
Ser Tyr Gly Gln
C19H27N5O8 (453.18595419999997)
Ser Tyr Lys Gly
Ser Tyr Asn Ala
C19H27N5O8 (453.18595419999997)
Ser Tyr Gln Gly
C19H27N5O8 (453.18595419999997)
Thr Gly Asn Tyr
C19H27N5O8 (453.18595419999997)
Thr Gly Tyr Asn
C19H27N5O8 (453.18595419999997)
Thr Asn Gly Tyr
C19H27N5O8 (453.18595419999997)
Thr Asn Tyr Gly
C19H27N5O8 (453.18595419999997)
Thr Tyr Gly Asn
C19H27N5O8 (453.18595419999997)
Thr Tyr Asn Gly
C19H27N5O8 (453.18595419999997)
Val Ala His Gln
Val Ala Gln His
Val His Ala Gln
Val His Gln Ala
Val Gln Ala His
Val Gln His Ala
Tyr Ala Asn Ser
C19H27N5O8 (453.18595419999997)
Tyr Ala Ser Asn
C19H27N5O8 (453.18595419999997)
Tyr Gly Lys Ser
Tyr Gly Asn Thr
C19H27N5O8 (453.18595419999997)
Tyr Gly Gln Ser
C19H27N5O8 (453.18595419999997)
Tyr Gly Ser Lys
Tyr Gly Ser Gln
C19H27N5O8 (453.18595419999997)
Tyr Gly Thr Asn
C19H27N5O8 (453.18595419999997)
Tyr Lys Gly Ser
Tyr Lys Ser Gly
Tyr Asn Ala Ser
C19H27N5O8 (453.18595419999997)
Tyr Asn Gly Thr
C19H27N5O8 (453.18595419999997)
Tyr Asn Ser Ala
C19H27N5O8 (453.18595419999997)
Tyr Asn Thr Gly
C19H27N5O8 (453.18595419999997)
Tyr Gln Gly Ser
C19H27N5O8 (453.18595419999997)
Tyr Gln Ser Gly
C19H27N5O8 (453.18595419999997)
Tyr Ser Ala Asn
C19H27N5O8 (453.18595419999997)
Tyr Ser Gly Lys
Tyr Ser Gly Gln
C19H27N5O8 (453.18595419999997)
Tyr Ser Lys Gly
Tyr Ser Asn Ala
C19H27N5O8 (453.18595419999997)
Tyr Ser Gln Gly
C19H27N5O8 (453.18595419999997)
Tyr Thr Gly Asn
C19H27N5O8 (453.18595419999997)
Tyr Thr Asn Gly
C19H27N5O8 (453.18595419999997)
Dihexanoyllecithin
C20H40NO8P (453.24914100000007)
PC(6:0/6:0)[S]
C20H40NO8P (453.24914100000007)
Dihexanoylphosphatidylcholine
C20H40NO8P (453.24914100000007)
20-Oxo-leukotriene E4
C23H35NO6S (453.21849700000007)
(S)-2-Fmoc-Amino-Heptanedioic Acid 7-Tert-Butyl Ester
Trioxifene
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
4-[3-(1-benzhydrylazetidin-3-yl)oxy-2-hydroxypropoxy]-1H-indole-2-carbonitrile
C28H27N3O3 (453.20523120000007)
SB590885
SB-590885 is a potent?B-Raf?inhibitor with?Ki?of 0.16 nM, and has 11-fold greater selectivity for B-Raf over c-Raf, without inhibition to other human kinases.
(2S,2S)-2-((2-amino-6-oxo-1H-purin-9(6H)-yl)methoxy)propane-1,3-diyl bis(2-amino-3-methylbutanoate)
Netarsudil
C28H27N3O3 (453.20523120000007)
S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent
1H-1-Benzazepine-5-acetamide, 1-(2-chloro-4-(1-pyrrolidinyl)benzoyl)-2,3,4,5-tetrahydro-N-(1-methylethyl)-, (R)-
Urea, N-((1R)-1-(((4S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethyl-1-piperidinyl)carbonyl)-2-methylpropyl)-N-(2-hydroxy-2-methylpropyl)-
C23H36ClN3O4 (453.2394206000001)
Ethoheptazine citrate
C22H31NO9 (453.19987160000005)
C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist
N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide
C23H30F3N3O3 (453.22391460000006)
(20s)-19,20,22,23-Tetrahydro-19-oxo-5h,21h-18,20-ethano-12,14-etheno-6,10-methenobenz[d]imidazo[4,3-l][1,6,9,13]oxatriazacyclonoadecosine-9-carbonitrile
[(2R)-1-[(2S)-2-[[(2S,3S)-1-Chloro-6-(diaminomethylideneamino)-2-hydroxyhexan-3-yl]carbamoyl]pyrrolidin-1-yl]-1-oxo-3-phenylpropan-2-yl]azanium
C21H34ClN6O3+ (453.23807840000006)
(5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-amino-2-carboxyethyl]sulfanyl}-5-hydroxy-20-oxoicosa-7,9,11,14-tetraenoic acid
C23H35NO6S (453.21849700000007)
2-(3-(2-Aminoethyl)-1h-indol-5-yloxy)acetyl-l-tyrosyl-glycinamide
C23H27N5O5 (453.20120920000005)
Benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone
3-Demethylstaurosporinium(1+)
C27H25N4O3+ (453.19265599999994)
Conjugate acid of 3-demethylstaurosporine.
3,5-Dimethyl-1-phenyl-4-pyrazolecarboxylic acid [2-[4-amino-1-methyl-3-(2-methylpropyl)-2,6-dioxo-5-pyrimidinyl]-2-oxoethyl] ester
C23H27N5O5 (453.20120920000005)
(3R,3aS,7R,7aS)-3-[3-(4-acetylphenyl)-4-fluorophenyl]-7-methyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one
(3R,3aR,7aR)-3-[4-(4-acetylphenyl)-2-fluorophenyl]-7a-methyl-2-(phenylmethyl)-3,3a,6,7-tetrahydroisoindol-1-one
(5aS,7S,8aR,9aS)-7,7,8,8-tetramethyl-5a-nitrospiro[1,2,3,5,6,8a,9,9a-octahydrocyclopenta[f]indolizine-7,3-1,8-dihydropyrano[2,3-g]indole]-2,9-dione
(E)-3,7,11,15-tetramethylhexadec-2-en-1-yl diphosphate(3-)
C20H39O7P2-3 (453.21709039999996)
N-[2-methyl-4-oxo-3-(phenylmethyl)-7-(1-piperidinyl)-6-quinazolinyl]-3-pyridinecarboxamide
3-butan-2-yl-1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-1-(2-phenylethyl)thiourea
C25H31N3O3S (453.20860160000007)
1-(4-amino-1,2,5-oxadiazol-3-yl)-5-(azepan-1-ylmethyl)-N-[(E)-(2-ethoxyphenyl)methylidene]-1H-1,2,3-triazole-4-carbohydrazide
1-(4-Amino-1,2,5-oxadiazol-3-YL)-N-[(E)-(2-ethoxyphenyl)methylidene]-5-[(4-methylpiperidin-1-YL)methyl]-1H-1,2,3-triazole-4-carbohydrazide
3-(3,4-dimethoxyphenyl)-2-methyl-N-[2-(4-morpholinyl)ethyl]-1-oxo-3,4-dihydroisoquinoline-4-carboxamide
1-(4-Amino-1,2,5-oxadiazol-3-YL)-N-[(E)-(4-ethoxyphenyl)methylidene]-5-[(4-methylpiperidin-1-YL)methyl]-1H-1,2,3-triazole-4-carbohydrazide
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C22H35N3O5S (453.2297300000001)
N-[[(2R,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C25H28FN3O4 (453.20637400000004)
1-[(1S)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
C25H28FN3O4 (453.20637400000004)
1-[(1R)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone
C25H28FN3O4 (453.20637400000004)
2-[(2R,3S,6S)-3-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
2-[(2R,3S,6R)-3-(1,3-benzodioxol-5-ylcarbamoylamino)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
methyl (1S,9R,10R,11R)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
2-[(2R,3R,6R)-3-(1,3-benzodioxol-5-ylcarbamoylamino)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
2-[(2R,3R,6R)-3-(1,3-benzodioxol-5-ylcarbamoylamino)-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
methyl (1R,9S,10S,11S)-5-[3-(dimethylcarbamoyl)phenyl]-10-(hydroxymethyl)-6-oxo-12-propyl-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C22H35N3O5S (453.2297300000001)
N-[(2S,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C22H35N3O5S (453.2297300000001)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
C21H31N3O6S (453.19334660000004)
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
C21H31N3O6S (453.19334660000004)
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
C21H31N3O6S (453.19334660000004)
N-[[(2R,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C25H28FN3O4 (453.20637400000004)
N-[[(2S,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C25H28FN3O4 (453.20637400000004)
N-[[(2R,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C25H28FN3O4 (453.20637400000004)
1-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
C22H35N3O5S (453.2297300000001)
1-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
C22H35N3O5S (453.2297300000001)
1-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
C22H35N3O5S (453.2297300000001)
2-[(2S,3S,6R)-3-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
2-[(2R,3R,6S)-3-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
N-[(2S,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C22H35N3O5S (453.2297300000001)
N-[(2R,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C22H35N3O5S (453.2297300000001)
N-[(2S,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C22H35N3O5S (453.2297300000001)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C24H27N3O6 (453.18997620000005)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C24H27N3O6 (453.18997620000005)
N-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C24H27N3O6 (453.18997620000005)
(3aR,4R,9bS)-8-(1-cyclohexenyl)-N-(2,5-difluorophenyl)-4-(hydroxymethyl)-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
C26H29F2N3O2 (453.22277180000003)
[(3aR,4S,9bS)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-pyridin-4-ylmethanone
C28H27N3O3 (453.20523120000007)
(6R,7R,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H28FN3O4 (453.20637400000004)
(6R,7R,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H28FN3O4 (453.20637400000004)
(6S,7S,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H28FN3O4 (453.20637400000004)
(6S,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H27N3O3 (453.20523120000007)
(6R,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H27N3O3 (453.20523120000007)
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclopropanecarboxamide
C21H31N3O6S (453.19334660000004)
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C22H35N3O5S (453.2297300000001)
N-[(2R,3S)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C22H35N3O5S (453.2297300000001)
N-[(2S,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C22H35N3O5S (453.2297300000001)
N-[(2R,3R)-2-[[cyclopropylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]methanesulfonamide
C22H35N3O5S (453.2297300000001)
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]cyclopropanecarboxamide
C21H31N3O6S (453.19334660000004)
N-[[(2S,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C25H28FN3O4 (453.20637400000004)
N-[[(2R,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C25H28FN3O4 (453.20637400000004)
N-[[(2S,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C25H28FN3O4 (453.20637400000004)
N-[[(2S,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide
C25H28FN3O4 (453.20637400000004)
1-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
C22H35N3O5S (453.2297300000001)
1-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
C22H35N3O5S (453.2297300000001)
1-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
C22H35N3O5S (453.2297300000001)
1-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
C22H35N3O5S (453.2297300000001)
1-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-1-methyl-3-propylurea
C22H35N3O5S (453.2297300000001)
2-[(2S,3R,6S)-3-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
2-[(2R,3S,6R)-3-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
2-[(2S,3S,6R)-3-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1S)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
2-[(2R,3R,6S)-3-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
2-[(2S,3S,6S)-3-[[(1,3-benzodioxol-5-ylamino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[(1R)-1-phenylethyl]acetamide
C24H27N3O6 (453.18997620000005)
N-[(2R,3S,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C22H35N3O5S (453.2297300000001)
N-[(2S,3R,6R)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C22H35N3O5S (453.2297300000001)
N-[(2R,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C22H35N3O5S (453.2297300000001)
N-[(2S,3S,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C22H35N3O5S (453.2297300000001)
N-[(2R,3R,6S)-6-[2-(benzenesulfonamido)ethyl]-2-(hydroxymethyl)-3-oxanyl]-3-(1-piperidinyl)propanamide
C22H35N3O5S (453.2297300000001)
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C24H27N3O6 (453.18997620000005)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C24H27N3O6 (453.18997620000005)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C24H27N3O6 (453.18997620000005)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-(4-morpholinyl)-2-oxoethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C24H27N3O6 (453.18997620000005)
(6S,7S,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H28FN3O4 (453.20637400000004)
(6R,7S,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H28FN3O4 (453.20637400000004)
(6S,7R,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one
C25H28FN3O4 (453.20637400000004)
(6S,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H27N3O3 (453.20523120000007)
(6S,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H27N3O3 (453.20523120000007)
(6R,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H27N3O3 (453.20523120000007)
(6R,7R,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one
C28H27N3O3 (453.20523120000007)
[(1S)-2-(cyclopropylmethyl)-1-[(2,5-difluorophenyl)methyl]-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]methanol
C26H29F2N3O2 (453.22277180000003)
(1R,9S,10S,11S)-10-(hydroxymethyl)-N-[2-(1-methylimidazol-4-yl)ethyl]-6-oxo-12-propanoyl-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
(1S,9R,10R,11R)-10-(hydroxymethyl)-N-[2-(1-methylimidazol-4-yl)ethyl]-6-oxo-12-propanoyl-5-[(Z)-prop-1-enyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
5-aminopentyl 3-O-(2-O-acetyl-6-deoxy-alpha-L-talopyranosyl)-beta-D-glucopyranoside
2-amino-3-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid
C19H36NO9P (453.2127576000001)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-butanoyloxypropan-2-yl] undecanoate
C20H40NO8P (453.24914100000007)
(3-Butanoyloxy-2-octanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C20H40NO8P (453.24914100000007)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] dodecanoate
C20H40NO8P (453.24914100000007)
(3-Acetyloxy-2-decanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C20H40NO8P (453.24914100000007)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] octanoate
C20H40NO8P (453.24914100000007)
(2-Heptanoyloxy-3-pentanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C20H40NO8P (453.24914100000007)
[1-Acetyloxy-3-[2-aminoethoxy(hydroxy)phosphoryl]oxypropan-2-yl] tridecanoate
C20H40NO8P (453.24914100000007)
(2-Nonanoyloxy-3-propanoyloxypropyl) 2-(trimethylazaniumyl)ethyl phosphate
C20H40NO8P (453.24914100000007)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] decanoate
C20H40NO8P (453.24914100000007)
[1-[2-Aminoethoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] nonanoate
C20H40NO8P (453.24914100000007)
1,2-Dihexanoyl-sn-glycero-3-PC
C20H40NO8P (453.24914100000007)
A phosphatidylcholine 12:0 in which both acyl groups are specified as hexanoyl.
20-oxoleukotriene E4
C23H35NO6S (453.21849700000007)
A leukotriene that is leukotriene E4 in which the terminal methyl grop has been oxidised to the corresponding aldehyde
phosphatidylcholine 12:0
C20H40NO8P (453.24914100000007)
A 1,2-diacyl-sn-glycero-3-phosphocholine in which the two acyl groups contain a total of 12 carbons and no double bonds.
Phe-Pro-Ala-pNA
C23H27N5O5 (453.20120920000005)
Phe-Pro-Ala-pNA is a chromogenic substrate of tripeptidyl peptidase. Phe-Pro-Ala-pNA can be used to test tripeptidyl peptidase activity[1].
Temuterkib
C22H27N7O2S (453.19468420000004)
Temuterkib (LY3214996) is a highly selective inhibitor of ERK1 and ERK2, with IC50 of 5 nM for both enzymes in biochemical assays. Temuterkib potently inhibits cellular p-RSK1 in BRAF and RAS mutant cancer cell lines. Temuterkib shows potent antitumor activities in cancer models with MAPK pathway alterations.
3-[3-(2-hydroxypropan-2-yl)-7-methyl-2,3-dihydro-1,4-benzodioxin-5-yl]-3-methoxy-4-(3-methylbut-2-en-1-yl)isoindole-1,7-diol
(2r)-2-[(9ar)-9a-methyl-3-octanoyl-2,9-dioxo-6-[(1e)-prop-1-en-1-yl]furo[3,2-g]isoquinolin-7-yl]propanoic acid
(1r,2s,3r,4r,4as,8ar)-1,3-dihydroxy-3,4,8,8a-tetramethyl-4-[(1e)-2-(5-oxo-2h-furan-3-yl)ethenyl]-2,4a,5,6-tetrahydro-1h-naphthalen-2-yl pyridine-3-carboxylate
2'-hydroxy-7',7',8,8-tetramethyl-5a-nitro-1,2,3,5,6,8a,9,9a-octahydro-8'h-spiro[cyclopenta[f]indolizine-7,3'-pyrano[2,3-g]indol]-9'-one
1,3-dihydroxy-3,4,8,8a-tetramethyl-4-[2-(5-oxo-2h-furan-3-yl)ethenyl]-2,4a,5,6-tetrahydro-1h-naphthalen-2-yl pyridine-3-carboxylate
6-{2-[5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]ethenyl}-3-methoxy-4-phenyl-3h-quinoline-2,4,5-triol
(1r,3r)-5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile
C23H27N5O5 (453.20120920000005)
(1r,3r,6s,13s,15s,16s,18s)-5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile
C23H27N5O5 (453.20120920000005)
7-({[3-(acetyloxy)-2-hydroxy-2-(1-methoxyethyl)-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-methylbut-2-enoate
(2e)-n-[(1s)-1-{[(2r)-3-methyl-1-{[(1r,2r)-2-methyl-1-[(3r)-2-oxooxolan-3-yl]pentyl]oxy}-1-oxobutan-2-yl]-c-hydroxycarbonimidoyl}ethyl]but-2-enediimidic acid
C22H35N3O7 (453.24748800000003)
(1s,13s,17s,19r)-9,13-dihydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11-hexaen-15-one
12-(acetyloxy)-n-{1,5,7-trihydroxy-10-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl}dodec-2-enimidic acid
(3s,4s)-6-[(1e)-2-[(2r,5r)-5-(2-hydroxypropan-2-yl)-2-methyloxolan-2-yl]ethenyl]-3-methoxy-4-phenyl-3h-quinoline-2,4,5-triol
9,13-dihydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11-hexaen-15-one
5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile
C23H27N5O5 (453.20120920000005)
(2e,4e)-n-[2-({1-[(3r)-5-hydroxy-4-methyl-2-oxo-3,4-dihydropyrrol-3-yl]-3-methyl-1-oxobutan-2-yl}-c-hydroxycarbonimidoyl)-1-phenylethyl]hexa-2,4-dienimidic acid
(2s)-2-[(9ar)-9a-methyl-3-octanoyl-2,9-dioxo-6-[(1e)-prop-1-en-1-yl]furo[3,2-g]isoquinolin-7-yl]propanoic acid
(5as,7s,8ar,9as)-2'-hydroxy-7',7',8,8-tetramethyl-5a-nitro-1,2,3,5,6,8a,9,9a-octahydro-8'h-spiro[cyclopenta[f]indolizine-7,3'-pyrano[2,3-g]indol]-9'-one
(2e,4e)-n-[(1s)-2-{[(2s)-1-[(3r,4s)-5-hydroxy-4-methyl-2-oxo-3,4-dihydropyrrol-3-yl]-3-methyl-1-oxobutan-2-yl]-c-hydroxycarbonimidoyl}-1-phenylethyl]hexa-2,4-dienimidic acid
(3r)-3-[(3s)-3-(2-hydroxypropan-2-yl)-7-methyl-2,3-dihydro-1,4-benzodioxin-5-yl]-3-methoxy-4-(3-methylbut-2-en-1-yl)isoindole-1,7-diol
2-amino-n-(4-carbamimidamido-1-{[hydroxy(1-hydroxy-2-methoxy-2-oxoethyl)phosphoryl](methyl)-c-hydroxycarbonohydrazonoyl}butyl)-3-methylbutanimidic acid
(1s,7ar)-7-({[(2r)-3-(acetyloxy)-2-hydroxy-2-[(1s)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
(3s)-3-[(3s)-3-(2-hydroxypropan-2-yl)-7-methyl-2,3-dihydro-1,4-benzodioxin-5-yl]-3-methoxy-4-(3-methylbut-2-en-1-yl)isoindole-1,7-diol
(1s,13r,17s,19s)-9,13-dihydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.1⁸,¹².0²,⁷.0¹⁹,²⁴]hexacosa-2(7),3,5,8(26),9,11-hexaen-15-one
(2e)-12-(acetyloxy)-n-[(1s,2s,4s,5s,6s,7r,8s)-1,5,7-trihydroxy-10-oxo-3-oxatricyclo[4.3.1.0²,⁴]decan-8-yl]dodec-2-enimidic acid
4,9-dihydroxy-9-isopropyl-8-methyl-4-(sec-butyl)-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
(1s,7ar)-7-({[(2s)-3-(acetyloxy)-2-hydroxy-2-[(1s)-1-methoxyethyl]-3-methylbutanoyl]oxy}methyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2z)-2-methylbut-2-enoate
(2e)-n-[(1s)-1-{[(2r)-3-methyl-1-{[(2r)-2-methyl-1-(2-oxooxolan-3-yl)pentyl]oxy}-1-oxobutan-2-yl]-c-hydroxycarbonimidoyl}ethyl]but-2-enediimidic acid
C22H35N3O7 (453.24748800000003)
2-[9a-methyl-3-octanoyl-2,9-dioxo-6-(prop-1-en-1-yl)furo[3,2-g]isoquinolin-7-yl]propanoic acid
2-{[(2e,4e,6e,8e,10e)-1-hydroxy-11-{3-hydroxy-2-[(1-hydroxyethylidene)amino]phenyl}undeca-2,4,6,8,10-pentaen-1-ylidene]amino}-4-(c-hydroxycarbonimidoyl)butanoic acid
C24H27N3O6 (453.18997620000005)
(1r,4s,8r,9s,19r)-4-[(2s)-butan-2-yl]-4,9-dihydroxy-9-isopropyl-8-methyl-2,7,11-trioxa-16-azatricyclo[11.5.1.0¹⁶,¹⁹]nonadec-13-ene-3,6,10-trione
(1r,3r,4r,6s,13s,15s,16s,18s)-5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile
C23H27N5O5 (453.20120920000005)